NASDAQ:ICLR - Icon Stock Price, Forecast & News

Icon trades on the NASDAQ under the ticker symbol "ICLR."

Icon Plc (NASDAQ:ICLR) posted its quarterly earnings data on Wednesday, February, 19th. The medical research company reported $1.83 earnings per share for the quarter, meeting analysts' consensus estimates of $1.83. The medical research company earned $725.40 million during the quarter, compared to analysts' expectations of $734.13 million. Icon had a net margin of 13.33% and a return on equity of 25.00%. The firm's revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the prior year, the company posted $1.62 EPS. View Icon's Earnings History.

Icon is scheduled to release their next quarterly earnings announcement on Wednesday, May 6th 2020. View Earnings Estimates for Icon.

Icon issued an update on its FY20 earnings guidance on Wednesday, February, 19th. The company provided EPS guidance of $7.55-7.85 for the period, compared to the Thomson Reuters consensus EPS estimate of $7.71. The company issued revenue guidance of $2.972-3.092 billion, compared to the consensus revenue estimate of $3.04 billion.

9 brokerages have issued 12 month price objectives for Icon's shares. Their forecasts range from $160.00 to $194.00. On average, they expect Icon's stock price to reach $178.75 in the next year. This suggests a possible upside of 11.4% from the stock's current price. View Analyst Price Targets for Icon.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Icon in the last year. There are currently 5 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Icon.

News articles about ICLR stock have trended somewhat positive on Tuesday, InfoTrie reports. The research firm scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Icon earned a coverage optimism score of 1.2 on InfoTrie's scale. They also gave news headlines about the medical research company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Icon.

Icon saw a increase in short interest during the month of January. As of January 15th, there was short interest totalling 1,180,000 shares, an increase of 16.8% from the December 31st total of 1,010,000 shares. Based on an average trading volume of 254,500 shares, the days-to-cover ratio is currently 4.6 days. Approximately 2.2% of the company's shares are short sold. View Icon's Current Options Chain.

Some companies that are related to Icon include Iqvia (IQV), Incyte (INCY), EXACT Sciences (EXAS), PPD (PPD), Charles River Laboratories Intl. (CRL), Syneos Health (SYNH), PRA Health Sciences (PRAH), Exelixis (EXEL), BTG (BTGGF), Medpace (MEDP), National Research (NRC), Intrexon (XON), Sorrento Therapeutics (SRNE), STARPHARMA HOLD/S (SPHRY) and Anavex Life Sciences (AVXL).

Based on aggregate information from My MarketBeat watchlists, some companies that other Icon investors own include Pfizer (PFE), Gilead Sciences (GILD), CVS Health (CVS), Mastercard (MA), Procter & Gamble (PG), Post (POST), Visa (V), Johnson & Johnson (JNJ), Exxon Mobil (XOM) and Amgen (AMGN).

Icon's stock is owned by a number of of institutional and retail investors. Top institutional investors include WCM Investment Management LLC (6.75%), Renaissance Technologies LLC (4.35%), Alliancebernstein L.P. (3.93%), Acadian Asset Management LLC (3.91%), Earnest Partners LLC (3.80%) and Comgest Global Investors S.A.S. (3.26%).

ICLR stock was sold by a variety of institutional investors in the last quarter, including Pendal Group Ltd, Janus Henderson Group PLC, Bank of New York Mellon Corp, Lord Abbett & CO. LLC, FMR LLC, PNC Financial Services Group Inc., Principal Financial Group Inc. and Alliancebernstein L.P..

ICLR stock was acquired by a variety of institutional investors in the last quarter, including Investec Asset Management LTD, Comgest Global Investors S.A.S., Massachusetts Financial Services Co. MA, FIL Ltd, Man Group plc, WCM Investment Management LLC, Knights of Columbus Asset Advisors LLC and Polen Capital Management LLC.

Shares of ICLR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ICLR stock can currently be purchased for approximately $160.46.

Icon has a market capitalization of $8.66 billion and generates $2.81 billion in revenue each year. The medical research company earns $373.99 million in net income (profit) each year or $6.88 on an earnings per share basis. Icon employs 13,670 workers across the globe.View Additional Information About Icon.

The official website for Icon is http://www.iconplc.com/.

Icon's mailing address is SOUTH COUNTY BUSINESS PARK LEOPARDSTOWN, DUBLIN L2, 00000. The medical research company can be reached via phone at 353-1291-2000.